Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)

Tuscaloosa Alabama 35404

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Arizona

Xenoscience
Phoenix Arizona 85004

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Research Center
Phoenix Arizona 85006

Are you concerned about memory loss?

Research Center
Sun City Arizona 85351

Are you concerned about memory loss?

View More ▼

Phoenix Arizona 85032

A clinical research study of AVP-786 and Placebo for the treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Phoenix Arizona 85013

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

Phoenix Arizona 85006

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona 85013

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

Sun City Arizona 85351

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Tucson Arizona 85704

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

Tucson Arizona 85704

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Arkansas

Research Center
Fayetteville Arkansas 72703

Are you concerned about memory loss?

View More ▼

Fayetteville Arkansas

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

California

Alliance Research Center
Laguna Hills California 92653

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Renew Behavioral Health, Inc.
Long Beach California 90807

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Research Center
Long Beach California 90806

Are you concerned about memory loss?

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

You may qualify for a medical research study evaluating an investigational drug for memory loss. Participants must be at least 50 years of age and have noticed changes in your memory or your judgment.

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Phase 3 Study of Two Doses of EVP-6125 or Placebo in Subjects with Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication

Excell Research, Inc.
Oceanside California 92056

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Asclepes Research Center
Panorama City California 91402

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Northern California Research
Sacramento California 95821

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Northern California Research
Sacramento California 95821

Patients with Mild-Moderate Alzheimer's Disease

Sharp Mesa Vista Hospital Clinical Research Center
San Diego California 92123

This study is a Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease.

San Francisco Clinical Research Center
San Francisco California 94530

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Schuster Medical Research Institute
Sherman Oaks California 91403

A Phase III, Randomized, Placebo-Controlled, Double Blind Clinical Trial to study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment (aMCI) due to Alzheimer’s Disease (prodromal AD).

Research Center
Sherman Oaks California 91403

Are you concerned about memory loss?

Research Center
Simi Valley California 93065

Are you concerned about memory loss?

Research Center
Valley Village California 91607

Are you concerned about memory loss?

View More ▼

Bellflower California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Costa Mesa California 92627

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Costa Mesa California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Fremont California 94538

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Glendale California

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Glendale California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Glendale California 91206

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

Irvine California 92868

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Irvine California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

La Habra California 90631

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

La Jolla California 92037

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)

Laguna Hills California 92653

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Laguna Hills California 92653

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Lemon Grove California

Patients are needed to participate in a clinical research study of ITI-007 and Placebo to evaluate Agitation in Dementia, Including Alzheimer's Disease

Long Beach California 90806

A clinical research study of AVP-786 and Placebo for the treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Long Beach California

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Long Beach California 90806

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712

Moffett Field California 94035-0128

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease or Dementia